Pharmacogenomics Market Growth and Industry Analysis

Pharmacogenomics Market Size Was Valued at USD 16.2 Billion in 2023, and is Projected to Reach USD 35.8 Billion by 2032, Growing at a CAGR of 9.2% From 2024-2032.

Pharmacogenomic is an aspect of pharmacogenetics that deals with the relationship between a person and the drug that is prescribed to him or her. Pharmacogenomics aims at using information concerning genetic factors that influence drug metabolism, effectiveness and toxicity to shape determinate treatment plans so as to maximise effectiveness while minimising side-effects. This field integrates Pharmacology and genomics to facilitate treatment and dosing therefore bringing about better health solutions. Pharmacogenomic evaluation is therefore central in enhancing effectiveness of drug therapies, limiting use of drugs whose outcomes are too often unpredictable as well as in the creation of efficient individualized therapeutic interventions.